Perdita Taylor‐Zapata

发表

Need for appropriate formulations for children: the national institute of child health and human development-pediatric formulations initiative, part 1.

D. Mattison, G. Giacoia, Perdita Taylor‐Zapata, 2007, International journal of pharmaceutical compounding.

Physiologically Based Pharmacokinetic Modeling of Meropenem in Preterm and Term Infants

B. Poindexter, M. Walsh, E. Eichenwald, 2021, Clinical Pharmacokinetics.

Eunice Kennedy Shriver National Institute of Child Health and Human Development Pediatric Formulation Initiative: selected reports from working groups.

D. Mattison, G. Giacoia, Perdita Taylor‐Zapata, 2008, Clinical therapeutics.

Eunice Kennedy Shriver National Institute of Child Health and Human Development Pediatrics Formulation Initiative: proceedings from the Second Workshop on Pediatric Formulations.

G. Giacoia, Perdita Taylor‐Zapata, A. Zajicek, 2012, Clinical therapeutics.

Use of Real‐World Data and Physiologically‐Based Pharmacokinetic Modeling to Characterize Enoxaparin Disposition in Children With Obesity

Mark J. Ramos, Karan R. Kumar, M. Laughon, 2022, Clinical pharmacology and therapeutics.

Drug studies in newborns: a therapeutic imperative.

G. Giacoia, Perdita Taylor‐Zapata, A. Zajicek, 2012, Clinics in perinatology.

First-Dose Pharmacokinetics of Lithium Carbonate in Children and Adolescents

J. McClellan, W. Jusko, J. Frazier, 2010, Journal of clinical psychopharmacology.

Population Pharmacokinetics and Exploratory Exposure‐Response Relationships of Diazepam in Children Treated for Status Epilepticus

J. Chamberlain, G. Kearns, D. Benjamin, 2018, CPT: pharmacometrics & systems pharmacology.

Development and Evaluation of a Virtual Population of Children with Obesity for Physiologically Based Pharmacokinetic Modeling

Karan R. Kumar, M. Laughon, G. Kearns, 2021, Clinical Pharmacokinetics.

Antihypertensive Drug Use By Children: Are the Drugs Labeled and Indicated?

J. Flynn, Perdita Taylor‐Zapata, Joseph T. Flynn, 2012, Journal of clinical hypertension.

Expediting Drug Development for Pediatric Inflammatory Bowel Disease: A Discussion With Stakeholders

A. Bousvaros, J. Rosh, J. Hyams, 2018 .

Making progress for how medicines are used in children.

D. Mattison, Perdita Taylor‐Zapata, 2007, Archives of pediatrics & adolescent medicine.

Need for appropriate formulations for children: the national institute of child health and human development-pediatric formulations initiative, part 2.

D. Mattison, G. Giacoia, Perdita Taylor‐Zapata, 2007, International journal of pharmaceutical compounding.

Research Gaps in Primary Pediatric Hypertension

S. Daniels, J. Flynn, E. Urbina, 2019, Pediatrics.

Lithium for the Maintenance Treatment of Bipolar I Disorder: A Double-Blind, Placebo-Controlled Discontinuation Study.

M. DelBello, J. Frazier, T. Clemons, 2019, Journal of the American Academy of Child and Adolescent Psychiatry.

Post-acute effectiveness of lithium in pediatric bipolar I disorder.

J. Frazier, T. Clemons, R. Findling, 2013, Journal of child and adolescent psychopharmacology.

Child and Adolescent Psychiatry and Mental Health the Collaborative Lithium Trials (colt): Specific Aims, Methods, and Implementation

J. McClellan, B. Brownstein, J. Frazier, 2022 .

Lithium in the Acute Treatment of Bipolar I Disorder: A Double-Blind, Placebo-Controlled Study

M. DelBello, J. Frazier, T. Clemons, 2015, Pediatrics.

Dosing strategies for lithium monotherapy in children and adolescents with bipolar I disorder.

J. McClellan, J. Frazier, T. Clemons, 2011, Journal of child and adolescent psychopharmacology.

Development of a Pediatric Adverse Events Terminology

Margaret Haber, Eric S. Kirkendall, Margaret W. Haber, 2017, Pediatrics.

Fluconazole Prophylaxis for the Prevention of Candidiasis in Premature Infants: A Meta-analysis Using Patient-level Data.

B. Poindexter, D. Kaufman, S. Shankaran, 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.